This opportunity is no longer accepting applications.
grant PAR-22-139

Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) (R01 Clinical Trial Not Allowed)

This grant opportunity invites research projects that use advanced cancer biology techniques to investigate how various types of radiation in radionuclide-based treatments, like radiopharmaceutical therapy, affect normal tissues, tumor cells, and the environment around tumors.

The purpose of this Funding Opportunity Announcement (FOA) is to solicit R01 research projects utilizing state-of-the-art cancer biology methods and model systems to study effects of different types of radiation used in radionuclide-based therapeutics (e.g., radiopharmaceutical therapy) on norma…

Funding Source

Agency: National Institutes of Health
Sub-agency: National Cancer Institute
Program: SBIR

Awards & funding

Award Ceiling: $500,000
Award Amount: $500,000

Dates

Opportunity Released: March 18, 2022
Open for Submission: March 18, 2022
Submission Deadline: May 7, 2025
Application Window Closes: May 7, 2025

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.